SMTL ID : 6ic0.1

Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 4

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x HAK: 3-[[8-(1-methylindol-6-yl)quinoxalin-6-yl]amino]-~{N}-pyrimidin-5-yl-pyridine-4-carboxamide(Non-covalent)

HAK.1: 21 residues within 4Å: Chain A: R.28, G.29, Y.32, I.33, S.135, C.137, V.142, N.146, E.149, V.150, V.197, V.200, G.201, L.221, I.224, V.226, Q.227, P.404, A.406 Ligands: POP.2, DMS.5 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.32, A:I.33, A:V.197, A:L.221 Hydrogen bonds: A:S.135, A:N.146, A:E.149, A:V.200

1 x POP: PYROPHOSPHATE 2-(Non-covalent)

POP.2: 12 residues within 4Å: Chain A: L.25, P.26, A.27, R.28, G.29, K.30, T.31, Y.32, V.150, K.151, Y.407 Ligands: HAK.1 14 PLIP interactions: 14 interactions with chain A Hydrogen bonds: A:L.25, A:A.27, A:R.28, A:G.29, A:K.30, A:T.31, A:Y.32 Water bridges: A:K.30, A:K.30, A:K.30, A:K.30 Salt bridges: A:K.30, A:K.151, A:K.151

1 x FLC: CITRATE ANION(Non-covalent)

FLC.3: 10 residues within 4Å: Chain A: V.53, G.54, R.57, F.70, R.81, A.108, T.109, R.115, R.172, Y.176 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.70 Hydrogen bonds: A:G.54, A:R.81, A:T.109 Water bridges: A:R.172, A:Y.176 Salt bridges: A:R.57, A:R.81, A:R.115, A:R.115, A:R.172

1 x F6P: 6-O-phosphono-beta-D-fructofuranose(Non-covalent)

F6P.4: 12 residues within 4Å: Chain A: R.235, N.242, I.247, G.248, E.305, Y.316, R.330, K.334, Y.345, Q.371, R.375, T.423 11 PLIP interactions: 11 interactions with chain A Hydrogen bonds: A:G.248, A:Y.316, A:Y.316, A:Y.345, A:Y.345, A:Q.371, A:Q.371 Water bridges: A:R.235 Salt bridges: A:R.330, A:K.334, A:R.375

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.5: 3 residues within 4Å: Chain A: N.146, E.149 Ligands: HAK.1 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:E.149

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Boutard, N. et al., Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties. Bioorg. Med. Chem. Lett. (2019)

Release Date

2019-01-23

Peptides

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3